Patent · US Active

Substituted quinolines as PDE-10 inhibitors

US9834564B2 · kind B2 · utility

0Cited by
2References
32Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 20, 2015
Grant dateDec 5, 2017
Priority date—
Expiry dateFeb 20, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are Cyclic Nucleotide Phosphodiesterase inhibitors, and pharmaceutical compositions thereof, useful for the treatment of, for example, central nervous system and metabolic diseases and disorder.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.